- Investing Ideas
- /
- Bangladeshi Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Bangladeshi Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
UPDATED May 18, 2022
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
4 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SQURPHARMASquare Pharmaceuticals | ৳217.50 | -2.1% | 2.2% | ৳192.8b | ৳313.67 | PS10.4x | E11.6% | 2.8% | ||
| BXPHARMABeximco Pharmaceuticals | ৳151.00 | -9.3% | -15.1% | ৳67.4b | ৳182.00 | PS11.7x | E12.3% | 2.3% | ||
| ACMELABACME Laboratories | ৳87.50 | -4.9% | 23.2% | ৳18.5b | n/a | PS9.9x | n/a | 2.9% | ||
| IBNSINAIBN SINA Pharmaceutical Industry | ৳285.70 | -2.3% | 18.7% | ৳8.9b | ৳370.00 | PS15.9x | S13.9% | 1.6% |
Page 1 of 1